Funding - January 26, 2016
AstraZeneca establish translational research fund
AstraZeneca together with GlaxoSmithKline and Johnson & Johnson has partnered with three universities, Imperial College London, the University of Cambridge and University College London (UCL), to create the Apollo Therapeutics Fund. This new consortium aims to convert outstanding academic science from the three universities into innovative medicines for a broad range of diseases. The fund […]